Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
    • JB Special Collection
    • JB Classic Spotlights
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JB
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Bacteriology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
    • JB Special Collection
    • JB Classic Spotlights
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JB
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
PLASMIDS AND TRANSPOSONS

P1 ParB Domain Structure Includes Two Independent Multimerization Domains

Jennifer A. Surtees, Barbara E. Funnell
Jennifer A. Surtees
Department of Molecular and Medical Genetics, University of Toronto, Toronto, Ontario M5S 1A8, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Barbara E. Funnell
Department of Molecular and Medical Genetics, University of Toronto, Toronto, Ontario M5S 1A8, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/JB.181.19.5898-5908.1999
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Fig. 1.
    • Open in new tab
    • Download powerpoint
    Fig. 1.

    (A) Sequences of the N-terminal tags of the purified fusion proteins used in this study. Tags A1 to A4 are encoded by pET19b-HMK and pJS124. Slightly different versions of the tag were generated as a result of cloning from different sources. In tag B, the HMK sequence has been eliminated in the cloning protocol (see Materials and Methods). The HMK recognition sequence is a phosphorylation site for the catalytic subunit of bovine HMK. (B) Sequence of ParB. The arrows indicate the N terminus of each proteolytic fragment identified in this work. Bands A to E were generated by trypsin digestion. Band F was produced by chymotrypsin digestion.

  • Fig. 2.
    • Open in new tab
    • Download powerpoint
    Fig. 2.

    Tryptic digestion of ParB and His-ParB. ParB (lanes P) and His-ParB (lanes H) were treated with trypsin at a protein/protease ratio of 1,000:1 (wt/wt) at 20°C for the indicated times. Digestion was stopped with 1% acetic acid. Proteolytic fragments were separated by electrophoresis in SDS–15% polyacrylamide gels and were visualized with Coomassie blue. Undigested ParB and His-ParB migrate with 44- and 50-kDa proteins, respectively. The arrows at the right indicate the major tryptic fragments identified in Table 3. Lane M, size markers.

  • Fig. 3.
    • Open in new tab
    • Download powerpoint
    Fig. 3.

    Chymotrypsin and trypsin digestion of His-ParB. (Left) Five micrograms of protein was incubated with increasing amounts of protease for 2 h at room temperature. Protein-to-protease ratios (wt/wt) were 100:1 (lanes a and i), 500:1 (lanes b and h), 1,000:1 (lanes c and g), and 5,000:1 (lanes d and f). Lane e, no protease. Arrows indicate the fragments whose N termini were sequenced. (Right) Tryptic digest (protein/protease ratio of 1,000:1) performed at 30°C for 7.5 h, illustrating an additional band (E) that was also sequenced. The positions of size markers are indicated beside each gel. Tryp, trypsin.

  • Fig. 4.
    • Open in new tab
    • Download powerpoint
    Fig. 4.

    Tryptic digestion of His-ParB, two C-terminal fragments (His-47-333 ParB and His-67-333 ParB), and two N-terminal fragments (His-1-293 ParB and His-1-274 ParB). For each time course, the protein-to-protease ratio was 1,000:1 (wt/wt), and the digestions were performed at room temperature. Arrows at the left indicate the major proteolytic fragments of His-ParB. M, size markers.

  • Fig. 5.
    • Open in new tab
    • Download powerpoint
    Fig. 5.

    Examples of filter tests to determine β-galactosidase activity in the yeast two-hybrid system. The light patches were white and the grey patches were blue on the filters. Each panel (A and B) is a separate filter, but the patches within each panel are from the same filter. The particular interactions tested are indicated at the right of each filter. Various ParB and ParB fragment interactions (A and B) and ParA-ParB interactions (B) are shown. GAL4-ACT is the GAL4 activation domain alone encoded by pACTII and represents one of the negative controls for these assays.

  • Fig. 6.
    • Open in new tab
    • Download powerpoint
    Fig. 6.

    Summary of dimerization assays with C-terminal fragments of ParB. In yeast two-hybrid analysis, the ParB fragments shown in the diagram were fused to the GAL4 activation domain and were tested against FL-ParB, 30-333 ParB, and 275-333 ParB (in the columns) that were fused to the GAL4 DNA binding domain. For the cross-linking experiments, ParB fragments fused to a polyhistidine tag (Table 2) were purified and examined in vitro (Materials and Methods). The results from the yeast two-hybrid experiments were categorized as follows: −, no color development on filter tests or no growth on plates without histidine; +, moderate color development and moderate growth in the absence of histidine; ++, dark blue color and good growth in the absence of histidine. ND, not determined. The DSP cross-linking results were similarly categorized: −, no cross-linking; +, some cross-linking activity; ++, strong cross-linking, often to completion. Neither set of categories is intended to imply relative strengths of the interactions, which are presumably dependent on the assay. The N termini of the tryptic proteolytic fragments are indicated above the schematic of ParB.

  • Fig. 7.
    • Open in new tab
    • Download powerpoint
    Fig. 7.

    Cross-linking of His-ParB and His-ParB fragments with DSP. Ten micrograms of protein was incubated with DSP at room temperature for the indicated times and analyzed by electrophoresis as described in Materials and Methods. Arrows indicate the positions of monomers and the brackets indicate the positions of cross-linked products (XL). (A) Cross-linking of His-ParB compared with that of His-47-333 ParB on an SDS–10% gel. His-ParB cross-links efficiently to a dimer-size and possibly a tetramer-size smear. Lane M, size markers. (B) Cross-linking of two smaller C-terminal fragments in the presence of DSP. His-87-333 ParB and His-275-333 were treated with DSP and analyzed on a 10% polyacrylamide gel (left) and a 12% polyacrylamide gel (right), respectively. (C) Cross-linking reactions of two N-terminal fragments of ParB, His-1-293 ParB, and His-1-177 ParB, in a 12% polyacrylamide gel.

  • Fig. 8.
    • Open in new tab
    • Download powerpoint
    Fig. 8.

    Summary of dimerization assays with N-terminal fragments of ParB. In yeast two-hybrid analysis, the ParB fragments shown in the diagram were fused to the GAL4 activation domain and were tested against FL-ParB and 30-333 ParB (in the columns) fused to the GAL4 DNA binding domain. For the cross-linking experiments, polyhistidine-tagged protein fusions were purified and tested in vitro. The categories are described in the legend to Fig. 6. ND, not determined.

  • Fig. 9.
    • Open in new tab
    • Download powerpoint
    Fig. 9.

    Model of ParB’s functional and structural domains. The shaded boxes represent regions of the protein involved in ParB-ParB and ParA-ParB interactions. Arrows indicate the N termini of the proteolytic fragments (A to F) identified in this study. We propose that the C-terminal self-association domain is required for ParB dimerization and the N-terminal self-association domain mediates oligomerization. The inhibitory region affects the self-association of ParB that is mediated by the N-terminal oligomerization domain, as measured by cross-linking assays. The ParA box indicates a region of ParB that is necessary for interactions with ParA. The lower black boxes predict the general structural domains of ParB, from proteolytic assays. Region I represents the protease-accessible N-terminal region, which may mean that it is less structured in solution. Region II is more stable and more protease resistant. Region IIa represents the smallest highly protease resistant region of ParB.

Tables

  • Figures
  • Table 1.

    Vectors and P1 plasmids

    VectorDescriptionMarker(s)aReference
    pAS1GAL4 DNA binding domain vectorTRP1, Apr16
    pACTIIGAL4 activation domain vectorLEU2, Apr16
    pET19b-HMKProtein expression vector; N-terminal 10-His tag; HMK phosphorylation siteApr8
    pJS124pET19b-HMK derivative; stop codons inserted in all 3 frames at BamHI siteAprThis study
    pJS9parB in pBluescript SK+AprThis study
    pJS10parB in pBluescript SK+; opposite orientation of pJS9AprThis study
    pJS49pJS10 withBglII site immediately upstream ofparBAprThis study
    • ↵a Apr indicates ampicillin resistance in E. coli. TRP1 and LEU2are nutritional markers in S. cerevisiae.

  • Table 2.

    Plasmids for yeast two-hybrid analysis and for protein expression

    PlasmidVectorParB fragmenta
    For yeast two-hybrid analysis
     pJS50pAS1FL-ParB
     pJS51pACTIIFL-ParB
     pMR2pAS130-333 ParB
     pMR4pACTII30-333 ParB
     pJS37pACTII47-333 ParB
     pJS38pACTII67-333 ParB
     pJS39pACTII87-333 ParB
     pJS40pACTII93-333 ParB
     pJS41pACTII187-333 ParB
     pJS44pACTII275-333 ParB
     pJS45pAS1275-333 ParB
     pJS141pACTII1-312 ParB
     pMBP1pACTII1-293 ParB
     pJS136pACTII1-277 ParB
     pJS139pACTII1-234 ParB
     pJS140pACTII1-189 ParB
     pJS138pACTII1-177 ParB
     pJS137pACTII1-128 ParB
     pJS182pACTII1-61 ParB
     pJS181pAS11-61 ParB
     pBEF217pACTIIFL-ParA
    For protein expression
     pJS12pET19b-HMKFL-ParB (tag A1)
     pJS117pET19b-HMK47-333 ParB (tag B)
     pJS118pET19b-HMK67-333 ParB (tag B)
     pJS119pET19b-HMK87-333 ParB (tag B)
     pJS120pET19b-HMK93-333 ParB (tag B)
     pMD11pET19b-HMK152-333 ParB (tag A2)
     pMD12pET19b-HMK175-333 ParB (tag A2)
     pJS121pJS124187-333 ParB (tag A3)
     pMD13pET19b-HMK267-333 ParB (tag A2)
     pJS123pJS124275-333 ParB (tag A3)
     pJS172pJS1241-312 ParB (tag A4)
     pJS151pJS1241-293 ParB (tag A4)
     pJS128pJS1241-277 ParB (tag A4)
     pJS189pJS1241-274 ParB (tag A4)
     pJS146pJS1241-245 ParB (tag A4)
     pJS164pJS1241-234 ParB (tag A4)
     pJS143pJS1241-189 ParB (tag A4)
     pJS144pJS1241-188 ParB (tag A4)
     pJS145pJS1241-182 ParB (tag A4)
     pJS129pJS1241-177 ParB (tag A4)
     pJS166pJS1241-128 ParB (tag A4)
     pJS149pJS1241-114 ParB (tag A4)
     pJS148pJS1241-61 ParB (tag A4)
     pJS198pJS12447-177 ParB (tag A3)
    • ↵a Sequences of the N-terminal tags are shown in Fig. 1A.

  • Table 3.

    N-terminal sequences of proteolytic fragments generated by trypsin and chymotrypsin

    BandaN-terminal sequencebStarts at position:Molecular mass (kDa)c
    Apparent (on gel)Predicted (to C terminus)
    A?-Thr-Ile-Lys-His-Gln8332.228.4
    BVal-Leu-Val-Thr-Asp12427.923.9
    CAsp-Val-Gln-Thr-Ala14226.821.9
    DAla-Leu-Gln-Ala-Ala18517.617.1
    EGlu/Gly-Ala-Ser-Leu-Leu2639.18.4
    FLys-?-Ile-Arg-Ser-Thr7932.228.9
    • ↵a Those indicated in Fig. 2 to 4.

    • ↵b The sequences were determined by Edman degradation, and the first five or six residues are shown. Despite blanks in some sequences, each was consistent with only one position in ParB, assuming that each N-terminal residue was preceded by either an arginine or a lysine for tryptic fragments and by a hydrophobic residue for chymotryptic fragments.

    • ↵c The apparent molecular masses were determined by linear regression analysis (Multi-Analyst software) of the protein gels, and the predicted masses were calculated on the assumption that the fragments extend to the C terminus of the protein.

PreviousNext
Back to top
Download PDF
Citation Tools
P1 ParB Domain Structure Includes Two Independent Multimerization Domains
Jennifer A. Surtees, Barbara E. Funnell
Journal of Bacteriology Oct 1999, 181 (19) 5898-5908; DOI: 10.1128/JB.181.19.5898-5908.1999

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Bacteriology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
P1 ParB Domain Structure Includes Two Independent Multimerization Domains
(Your Name) has forwarded a page to you from Journal of Bacteriology
(Your Name) thought you would be interested in this article in Journal of Bacteriology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
P1 ParB Domain Structure Includes Two Independent Multimerization Domains
Jennifer A. Surtees, Barbara E. Funnell
Journal of Bacteriology Oct 1999, 181 (19) 5898-5908; DOI: 10.1128/JB.181.19.5898-5908.1999
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Bacteriophage P1
Viral Proteins

Related Articles

Cited By...

About

  • About JB
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #Jbacteriology

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0021-9193; Online ISSN: 1098-5530